By using our website you accept our cookies policy.Find out more

Neurotechnology SIG Webinar Series: Developing the UK’s Neurotechnology Capabilities

Event details
Tuesday, 13 October 2020
10:00 am – 12:00 pm
This event will be live streamed via webcast
In this webinar, three of UK’ s leading centres in neurotechnology will demonstrate how you can develop your neurotechnology and take it to market.

This is the third webinar in the series, brought to you by the KTN’s Neurotechnology Special Interest Group (SIG).

Neurotechnology is an incredibly multidisciplinary endeavour, covering areas as diverse as fundamental neuroscience, bioelectronic engineering, artificial intelligence and materials science. There are also a number of intellectual property and regulatory stages that need to be passed to get a new neurotechnology innovation to market. It is likely, therefore, that many companies will not have all these areas covered in house.

The featured leading centres are:

The Henry Royce Institute

Centre for Process Innovation (CPI)

The Manufacture of Active Implant and Surgical Instruments (MAISI)

Keynote Speakers

Thomas Beale
Commercial Development Manager – MedTech, Centre for Process Innovation (CPI)

Their expertise covers the entire development cycle, supporting you from initial concept through to adoption of your device in healthcare. Their scientific teams provide the most suitable technical support, helping you overcome your specific challenges. CPI brings you complementary resources to support your existing capabilities and ensure the full potential of your medtech innovation is realised.

Alex Casson
Reader (Associate Professor)
University of Manchester, The Henry Royce Institute

This is the UK’s national institute for advanced materials research and innovation. From equipment access for commercially sensitive research to long-term partnerships, the Royce can work flexibly and support a range of approaches and needs.

Dr. Anne Vanhoestenberghe
Deputy Director
The Manufacture of Active Implant and Surgical Instruments (MAISI)

King’s College, London School of Biomedical Engineering & Imaging Sciences, in partnership with UCL and Newcastle University, received a Wellcome grant of £5.2 million to establish a new facility for the Manufacture of Active Implant and Surgical Instruments (MAISI), which will be located at St Thomas’ Hospital.

Related Events